These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 27522034)

  • 21. Pharmacist-to-prescriber intervention to close therapeutic gaps for statin use in patients with diabetes: A randomized controlled trial.
    Renner HM; Hollar A; Stolpe SF; Marciniak MW
    J Am Pharm Assoc (2003); 2017; 57(3S):S236-S242.e1. PubMed ID: 28506378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does statin use have a disease modifying effect in symptomatic knee osteoarthritis? Study protocol for a randomised controlled trial.
    Wang Y; Tonkin A; Jones G; Hill C; Ding C; Wluka AE; Forbes A; Cicuttini FM
    Trials; 2015 Dec; 16():584. PubMed ID: 26700937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Medicines Advice Service Evaluation (MASE): a randomised controlled trial of a pharmacist-led telephone based intervention designed to improve medication adherence.
    Lyons I; Barber N; Raynor DK; Wei L
    BMJ Qual Saf; 2016 Oct; 25(10):759-69. PubMed ID: 26755665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effectiveness of diabetes medication therapy adherence clinic to improve glycaemic control among patients with type 2 diabetes mellitus: a randomised controlled trial.
    Alison C; Anselm S
    Med J Malaysia; 2020 May; 75(3):246-253. PubMed ID: 32467540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of generic substitution on refill adherence to statin therapy: a nationwide population-based study.
    Trusell H; Sundell KA
    BMC Health Serv Res; 2014 Dec; 14():626. PubMed ID: 25475416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term effects following 4 years of randomized treatment with atorvastatin in patients with type 2 diabetes mellitus on hemodialysis.
    Krane V; Schmidt KR; Gutjahr-Lengsfeld LJ; Mann JF; März W; Swoboda F; Wanner C;
    Kidney Int; 2016 Jun; 89(6):1380-7. PubMed ID: 26924051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of atorvastatin on C-reactive protein and benefits for cardiovascular disease in patients with type 2 diabetes: analyses from the Collaborative Atorvastatin Diabetes Trial.
    Soedamah-Muthu SS; Livingstone SJ; Charlton-Menys V; Betteridge DJ; Hitman GA; Neil HA; Bao W; DeMicco DA; Preston GM; Fuller JH; Stehouwer CD; Schalkwijk CG; Durrington PN; Colhoun HM;
    Diabetologia; 2015 Jul; 58(7):1494-502. PubMed ID: 25899452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.
    Colhoun HM; Betteridge DJ; Durrington PN; Hitman GA; Neil HA; Livingstone SJ; Thomason MJ; Mackness MI; Charlton-Menys V; Fuller JH;
    Lancet; 2004 Aug 21-27; 364(9435):685-96. PubMed ID: 15325833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of the statin choice encounter decision aid in Spanish patients with type 2 diabetes: A randomized trial.
    Perestelo-Pérez L; Rivero-Santana A; Boronat M; Sánchez-Afonso JA; Pérez-Ramos J; Montori VM; Serrano-Aguilar P
    Patient Educ Couns; 2016 Feb; 99(2):295-9. PubMed ID: 26343571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MAP study: RCT of a medication adherence program for patients with type 2 diabetes.
    Odegard PS; Christensen DB
    J Am Pharm Assoc (2003); 2012; 52(6):753-62. PubMed ID: 23229961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular risk outcome and program evaluation of a cluster randomised controlled trial of a community-based, lay peer led program for people with diabetes.
    Riddell MA; Dunbar JA; Absetz P; Wolfe R; Li H; Brand M; Aziz Z; Oldenburg B;
    BMC Public Health; 2016 Aug; 16(1):864. PubMed ID: 27558630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of a smartphone application (Perx) on medication adherence and clinical outcomes: a 12-month randomised controlled trial.
    Li A; Del Olmo MG; Fong M; Sim K; Lymer SJ; Cunich M; Caterson I
    BMJ Open; 2021 Aug; 11(8):e047041. PubMed ID: 34373299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Financial Incentives to Physicians, Patients, or Both on Lipid Levels: A Randomized Clinical Trial.
    Asch DA; Troxel AB; Stewart WF; Sequist TD; Jones JB; Hirsch AG; Hoffer K; Zhu J; Wang W; Hodlofski A; Frasch AB; Weiner MG; Finnerty DD; Rosenthal MB; Gangemi K; Volpp KG
    JAMA; 2015 Nov; 314(18):1926-35. PubMed ID: 26547464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does point-of-care testing lead to the same or better adherence to medication? A randomised controlled trial: the PoCT in General Practice Trial.
    Gialamas A; Yelland LN; Ryan P; Willson K; Laurence CO; Bubner TK; Tideman P; Beilby JJ
    Med J Aust; 2009 Nov; 191(9):487-91. PubMed ID: 19883342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of Digital Medicines to Improve Clinical Outcomes in Patients with Uncontrolled Hypertension and Type 2 Diabetes: Prospective, Open-Label, Cluster-Randomized Pilot Clinical Trial.
    Frias J; Virdi N; Raja P; Kim Y; Savage G; Osterberg L
    J Med Internet Res; 2017 Jul; 19(7):e246. PubMed ID: 28698169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of fenofibric acid co-administered with low- or moderate-dose statin in patients with mixed dyslipidemia and type 2 diabetes mellitus: results of a pooled subgroup analysis from three randomized, controlled, double-blind trials.
    Jones PH; Cusi K; Davidson MH; Kelly MT; Setze CM; Thakker K; Sleep DJ; Stolzenbach JC
    Am J Cardiovasc Drugs; 2010; 10(2):73-84. PubMed ID: 20136164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mobile Exergaming for Health-Effects of a serious game application for smartphones on physical activity and exercise adherence in type 2 diabetes mellitus-study protocol for a randomized controlled trial.
    Höchsmann C; Walz SP; Schäfer J; Holopainen J; Hanssen H; Schmidt-Trucksäss A
    Trials; 2017 Mar; 18(1):103. PubMed ID: 28264717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Helping patients with type 2 diabetes mellitus make treatment decisions: statin choice randomized trial.
    Weymiller AJ; Montori VM; Jones LA; Gafni A; Guyatt GH; Bryant SC; Christianson TJ; Mullan RJ; Smith SA
    Arch Intern Med; 2007 May; 167(10):1076-82. PubMed ID: 17533211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of a brief theory-based health promotion intervention among adults at high risk of type 2 diabetes: One-year results from a randomised trial in a community setting.
    Juul L; Andersen VJ; Arnoldsen J; Maindal HT
    Prim Care Diabetes; 2016 Apr; 10(2):111-20. PubMed ID: 26259517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of ATorvastatin On Chronic subdural Hematoma (ATOCH): a study protocol for a randomized controlled trial.
    Jiang R; Wang D; Poon WS; Lu YC; Li XG; Zhao SG; Wang RZ; You C; Yuan XR; Zhang JM; Feng H; Fei Z; Yu XG; Zhao YL; Hu J; Kang DZ; Yu RT; Gao GD; Zhu XD; Sun T; Hao JH; Liu XZ; Su N; Yue SY; Zhang JN
    Trials; 2015 Nov; 16():528. PubMed ID: 26581842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.